Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)
Eligible for screening study DCP 001
C0014 is closed to accrual, effective March 20, 2026.